TIAA CREF Investment Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
FAM
EAM
TCM
TIAA CREF Investment Management's TNDM Position: Q1 2019 in Review
TIAA CREF Investment Management increased its Tandem Diabetes Care (TNDM) stake by 13% in Q1 2019, buying an estimated $625K and bringing the position to 106,317 shares worth $6.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1265.
TIAA CREF Investment Management first reported a position in TNDM in Q4 2013 and has held it in 17 quarters since. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.
- TIAA CREF Investment Management held 106,317 shares of Tandem Diabetes Care worth $6.75M as of Q1 2019.
- TIAA CREF Investment Management bought 11,889 Tandem Diabetes Care shares in Q1 2019, an estimated $625K.
- Tandem Diabetes Care made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1265 holding.
- TIAA CREF Investment Management first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 17 quarters since.
- 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.
Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.